Formycon Aktie
WKN DE: A1EWVY / ISIN: DE000A1EWVY8
11.11.2024 15:35:05
|
EQS-PVR: Formycon AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Voting Rights Announcement: Formycon AG
Notification of Major Holdings
1. Details of issuer
2. Reason for notification
3. Details of person subject to the notification obligation
4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3. 5. Date on which threshold was crossed or reached:
6. Total positions
7. Details on total positions a. Voting rights attached to shares (Sec. 33, 34 WpHG)
b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
8. Information in relation to the person subject to the notification obligation
9. In case of proxy voting according to Sec. 34 para. 3 WpHG (only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG) Date of general meeting: Holding total positions after general meeting (6.) after annual general meeting:
10. Other explanatory remarks: Date
11.11.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Formycon AG |
Fraunhoferstraße 15 | |
82152 Planegg-Martinsried | |
Germany | |
Internet: | www.formycon.com |
End of News | EQS News Service |
|
2027225 11.11.2024 CET/CEST

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Formycon AGmehr Nachrichten
17:59 |
Aufschläge in Frankfurt: Schlussendlich Pluszeichen im SDAX (finanzen.at) | |
15:59 |
Gute Stimmung in Frankfurt: SDAX nachmittags im Plus (finanzen.at) | |
12:27 |
Gewinne in Frankfurt: SDAX klettert mittags (finanzen.at) | |
12:03 |
AKTIE IM FOKUS 2: Formycon klar erholt - Einigung auf US-Start für FYB203 (dpa-AFX) | |
11:20 |
ROUNDUP: Formycon legt US-Patentstreit zu Eylea-Biosimilar bei - Kurssprung (dpa-AFX) | |
09:30 |
Börse Frankfurt in Grün: SDAX zum Start des Donnerstagshandels auf grünem Terrain (finanzen.at) | |
08:45 |
Formycon legt Patentstreit zu Eylea-Biosimilar in USA bei - Kurssprung (dpa-AFX) | |
06:30 |
EQS-News: Formycon sichert US-Vermarktungsstart für Aflibercept-Biosimilar FYB203 durch Settlement-Vereinbarung mit Regeneron (EQS Group) |
Analysen zu Formycon AGmehr Analysen
09:32 | Formycon Outperform | RBC Capital Markets | |
17.09.25 | Formycon Outperform | RBC Capital Markets | |
20.08.25 | Formycon Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
13.08.25 | Formycon Outperform | RBC Capital Markets | |
13.08.25 | Formycon Buy | Warburg Research |
Aktien in diesem Artikel
Formycon AG | 25,65 | 12,25% |
|